Cell and Gene Outsourcing

  1. CGT Manufacturing Shifts From Capacity To Strategy 5/21/2026

    As manufacturing overcapacity reshapes the CGT landscape, success now depends less on access to capacity and more on strategic alignment across development, regulatory readiness, and long-term commercialization.

  2. Where Formulation Expertise Connects 5/20/2026

    As pipelines grow more complex and timelines become more ambitious, companies increasingly rely on strong external partners to advance their drug products efficiently and with reduced risk. 

  3. Safeguarding Biologic Quality And Performance 5/19/2026

    A science‑driven roadmap, from QTPP to QbD and phase‑appropriate strategies, helps ensure biologics stability, manufacturability, and a smooth path to successful commercialization

  4. Enhancing Biologics Developability With Predictive In Silico Modelling 5/19/2026

    Predictive in silico modeling accelerates biologics development by identifying stability and formulation risks early, enabling smarter candidate selection, reduced costs, and improved success rates.

  5. A Blueprint For Clinical-Grade Gene Therapy Production 5/19/2026

    View a scalable, open-access AAV9 manufacturing process improving yield, purity, and consistency through optimized transfection and downstream purification for clinical-grade gene therapy production.

  6. Turning Gene Therapies Into Patient Reality: Large Scale Cost-Effective AAV Production 5/19/2026

    Understanding how upstream control, downstream efficiency, and process robustness scale together is essential for protecting supply and expanding patient access.

  7. Viral Vector CDMO Services 5/18/2026

    Scale your viral vector program with confidence: 20+ years CGMP experience, 1,200+ GMP lots, and 3 approved products. Access full-service manufacturing from IND to commercial.

  8. Plasmid-Free DNA Platform For Better Starting Material 5/18/2026

    Optimized synthetic DNA enables scalable gene and RNA therapies with improved stability, expression, and delivery, supporting advanced applications across viral, non-viral, and vaccine platforms.

  9. Gene To GMP, Translating Concept Into Cure 5/18/2026

    An integrated platform unites synthetic DNA production with advanced therapy development and GMP manufacturing, streamlining workflows while improving speed, scalability, and control.

  10. How Peptides Became Cornerstones Of Modern Medicine 5/18/2026

    Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.